Greenlight Biosciences Cash Per Share vs. Return On Equity
| GRNADelisted Stock | USD 0.30 0.00 0.00% |
For Greenlight Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Greenlight Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Greenlight Biosciences Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Greenlight Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Greenlight Biosciences Holdings over time as well as its relative position and ranking within its peers.
Greenlight |
Greenlight Biosciences Return On Equity vs. Cash Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Greenlight Biosciences's current stock value. Our valuation model uses many indicators to compare Greenlight Biosciences value to that of its competitors to determine the firm's financial worth. Greenlight Biosciences Holdings is rated below average in cash per share category among its peers. It is rated below average in return on equity category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Greenlight Biosciences' earnings, one of the primary drivers of an investment's value.Greenlight Return On Equity vs. Cash Per Share
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Greenlight Biosciences |
| = | 0.36 X |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Greenlight Biosciences |
| = | -3.67 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Greenlight Return On Equity Comparison
Greenlight Biosciences is currently under evaluation in return on equity category among its peers.
Greenlight Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Greenlight Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Greenlight Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Greenlight Biosciences' change in net profit over the period of time. It can combine multiple indicators of Greenlight Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid products for human health and agriculture applications. The company was founded in 2008 and is headquartered in Medford, Massachusetts. Greenlight Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Greenlight Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Greenlight Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Greenlight Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Greenlight Biosciences' important profitability drivers and their relationship over time.
Use Greenlight Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Greenlight Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Greenlight Biosciences will appreciate offsetting losses from the drop in the long position's value.Greenlight Biosciences Pair Trading
Greenlight Biosciences Holdings Pair Trading Analysis
The ability to find closely correlated positions to Greenlight Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Greenlight Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Greenlight Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Greenlight Biosciences Holdings to buy it.
The correlation of Greenlight Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Greenlight Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Greenlight Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Greenlight Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Greenlight Biosciences position
In addition to having Greenlight Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Wholesale Thematic Idea Now
Wholesale
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Wholesale theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wholesale Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Greenlight Stock
If you are still planning to invest in Greenlight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Greenlight Biosciences' history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |